close Icon

Technologies

At Burnet, our technical breadth across laboratory research expertise, and technical skills and insight of public health professionals enables us to develop technologies that solve problems in the real world.  

Technologies

At Burnet, our technical breadth across laboratory research expertise, and technical skills and insight of public health professionals enables us to develop technologies that solve problems in the real world.  

Technologies

We develop technologies that enable breakthroughs in Diagnostics, Antibody Platforms, Therapeutics and Vaccines.

Vaccines

The Burnet Vaccine Initiative (BVI) aims to develop a pipeline of novel vaccines across a variety of modalities (protein, DNA vector, mRNA) through four parallel development streams.

Therapeutics

We are developing biologic and small molecule therapeutics that have potential application in women's health, infectious disease & immunological conditions.

Diagnostics

The Burnet Diagnostics Initiative (BDI) is producing commercially viable products for unmet health needs. 

Antibody Platforms

We are developing platforms to enhance efficacy of antibodies, Fc-fusion proteins, and antibody-like biologics that have potential application in oncology, infectious disease and immunological conditions.

BURNET Manifesto R5 July 0033 Crop1

Commercialisation at Burnet

In collaboration with our laboratory, clinical and field researchers, we work to achieve real world impact by effectively translating scientific innovation into products or services. To achieve these impacts, our team of commercialisation specialists identify market opportunity, develop business plans, secure external funding, protect intellectual property, and establish industry partnerships.

Find out more

News
+ Updates

The latest on how Burnet is closing the gap in health equity through a combination of collaborations and partnerships, established systems, resources and processes, and practical solutions for unmet health needs.

VIEW ALL POSTS
Cancer Cells 541954 960 720 Pixabay 980 X 625
Exciting technology opens the door to new treatments for cancer and infectious diseases
16 Nov 2023 News Post
Dreamstime Xxl 207054080
Burnet Institute partners with Moderna to develop novel mRNA vaccines
18 May 2022 News Post
Burnet Institute Marketing Nov 2018 002 Gilda Tachedjian 510X288
Burnet teams up with Monash and BioCurate to develop novel HIV antivirals
04 Aug 2022 News Post
Rectangle 47

Partnership
Opportunities

In collaboration with commercial partners we develop its intellectual property (IP) and over many years have developed a number of applications that are now in use around the world. Collaborate and partner with us in translating research into tangible commercial outcomes.

Contact us